Glucocorticoid potentiation of cytochrome P4501A1 induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in porcine and human endothelial cells in culture

Biochemical and Biophysical Research Communications

Volumn 232, Issue 3, 1997, Pages 749-753

  Celander, Malin ^a,c   Weisbrod, Robert ^b   Stegeman, John J ^a  

^a WOODS HOLE OCEANOGRAPHIC INSTITUTION   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYTOCHROME P450; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR;

ANIMAL CELL; AORTA; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENDOTHELIUM CELL; HEART DISEASE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SWINE;

EID: 17744417304     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.6366     Document Type: Article

References (30)

1. Juchau M. R., Bond J. A., Benditt E. P. Proc. Natl. Acad. Sci. USA. 73:1976;3723-3725.
2. Hoorn C. M., Wagner J. G., Roth R. A. Toxicol. Appl. Pharmacol. 120:1993;281-287.
3. J. L. Holtzman, M. J. Thirman, J. H. Albrecht, M. A. Krueger, R. R. Erickson, D. L. Cherwitz, S. S. Park, H. V. Gelboin, 1996, Presented at the XIth International Symposium on Microsomes and Drug Oxidations, University of California at Los Angeles, USA, July, 21, 24.
4. Dees J. H., Masters B. S. S., Muller-Eberhard U., Johnson E. F. Cancer Res. 42:1982;1423-1432.
5. Anderson L. M., Ward J. M., Park S. S., Jones A. B., Junker J. L., Gelboin H. V., Rice J. M. Cancer Res. 47:1987;6079-6085.
6. Stegeman J. J., Miller M. R., Hinton D. E. Mol. Pharmacol. 36:1989;723-729.
7. Thirman M. J., Albrecht J. H., Krueger M. A., Erickson R. R., Cherwitz D. L., Park S. S., Gelboin H. V., Holtzman J. L. Proc. Natl. Acad. Sci. USA. 91:1994;5397-5401.
8. Brittebo E. B. Carcinogenesis. 15:1994;667-672.
9. P. D. Guiney, M. K. Walker, R. E. Peterson, 1996, Proceedings of the Society of Environmental Toxicology and Chemistry Meeting, Arlington, Virginia, 1996, Abstract No. 388, 96.
10. Mathis J. M., Prough R. A., Hines R. N., Bresnick E., Simpson E. R. Arch. Biochem. Biophys. 246:1986;439-448.
11. Mathis J. M., Prough R. A., Simpson E. R. Arch. Biochem. Biophys. 244:1986;650-661.
12. Celander M., Hahn M. E., Stegeman J. J. Arch. Biochem. Biophys. 329:1996;113-122.
13. Hines R. N., Mathis J. M., Jacob C. S. Carcinogenesis. 9:1988;1599-1605.
14. Mathis J. M., Houser W. H., Bresnick E., Cidlowski J. A., Hines R. N., Prough R. A., Simpson E. R. Arch. Biochem. Biophys. 269:1989;93-105.
15. Stegeman J. J., Hahn M. E., Weisbrod R., Woodin B. R., Joy J. S., Najib S., Cohen R. A. Mol. Pharmacol. 47:1995;296-306.
16. Hahn M. E., Woodward B. L., Stegeman J. J., Kennedy S. W. Environ. Toxicol. Chem. 15:1996;582-591.
17. Kennedy S. W., Jones S. P. Anal. Biochem. 222:1994;217-223.
18. Burnette W. N. Anal. Biochem. 112:1981;195-203.
19. Park S. S., Miller H., Klotz A. V., Kloepper-Sams P. J., Stegeman J. J., Gelboin H. V. Arch. Biochem. Biophys. 249:1986;339-350.
20. Waziers D. E. I., Cugnenc P. H., Yang C. S., Leroux J. P., Beaune P. H. J. Pharmacol. Exp. Ther. 253:1990;387-394.
21. Schuetz E. G., Guzelian P. S. J. Biol. Chem. 259:1984;2007-2012.
22. Silver G., Reid L. M., Krauter K. S. J. Biol. Chem. 265:1990;3134-3138.
23. Wiebel F. J., Cikryt P. Chem.-Biol. Interact. 76:1990;307-320.
24. Celander M., Bremer J., Hahn M. E., Stegeman J. J. Environ. Toxicol. Chem. 16:1997.
25. Sidhu J. S., Omiecinski C. J. Pharmacogenetics. 5:1995;24-36.
26. Toborek M., Barger S. W., Mattson M. P., Espandiari P., Robertson L. W., Hennig B. J. Biochem. Toxicol. 10:1995;219-226.
27. Pinto A., Abraham N. G., Mullane K. M. J. Pharmacol. Exp. Ther. 240:1987;856-862.
28. Rifkind A. B., Gannon M., Gross S. S. Biochem. Biophys. Res. Commun. 172:1990;1180-1188.
29. McGiff J. C. Annu. Rev. Pharmacol. Toxicol. 31:1991;330-369.
30. Kanetoshi A., Ward A. M., May B. K., Rifkind A. B. Mol. Pharmacol. 42:1992;1020-1026.